About Methodos Laboratorio
Methodos Laboratorio is a Healthcare company based in Pouso Alegre (Brazil) founded in 1986, and was acquired by Fleury Group in October 2022. Clinical laboratory services are operated through a Brazilian chain. Its website methodoslab.com.br draws about 13 thousand monthly visits. Methodos Laboratorio offers products and services including Exam Results Platform and Home Collection Service. Its focus areas include Clinical Laboratory Chains and Diversified. Its competitors include Hermes Pardini, Bioanlise and Confiance Medicina Diagnostica.
Company details
Methodos Laboratorio was founded in 1986 and functions as a chain of clinical laboratories in Brazil. Operations are centered in Pouso Alegre, with services focused on diagnostic testing and medical analysis. The company serves healthcare needs across the region, providing laboratory examinations and related support in the medical sector. Expansion has been maintained through multiple sites to cover local demands.
- Headquarters Pouso Alegre, Brazil
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website methodoslab.com.br
- Social LinkedIn Facebook Instagram YouTube
- Acquired by Fleury Group (Oct 2022)
- Investors
- Acquired byFleury Group
(Oct 2022)
Products & Services of Methodos Laboratorio
Methodos Laboratorio offers a comprehensive portfolio of products and services, including Exam Results Platform and Home Collection Service.
Online platform for accessing and managing clinical exam results securely.
Doorstep sample collection for clinical analyses and hematology tests.
Apps and channels of Methodos Laboratorio
its YouTube channel Méthodos Laboratório has 92 subscribers and 30 videos.
Videos from Methodos Laboratorio
The most watched videos on Methodos Laboratorio's YouTube channel, Méthodos Laboratório (92 subscribers). Click a video to play it here.
More on Méthodos Laboratório.
Investors in Methodos Laboratorio
Methodos Laboratorio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fleury Medicina e Saúde.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medical diagnostic services are provided in Brazil by Fleury Group. | 1926 | fleury.com.br | Sao Paulo, Brazil |
Investor details for Methodos Laboratorio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Methodos Laboratorio
2 dated milestones of Methodos Laboratorio across 36 years, from founding to its latest funding, stage changes and deals.
- Founded Methodos Laboratorio is founded.
- Exit Acquired by Fleury Group.
Competitors of Methodos Laboratorio
Methodos Laboratorio has 3 listed competitors in our database. They include Hermes Pardini, Bioanlise and Confiance Medicina Diagnostica.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hermespardini.com.br | 1959 | Belo Horizonte, Brazil | Chain of clinical diagnostic testing and medical imaging laboratories | |||
| bioanalise.com.br | 1996 | Teresina, Brazil | Chain of clinical laboratories | |||
| confiance.com.br | 2001 | Campinas, Brazil | Medical laboratory providing diagnostic testing and vaccine services |
Detailed competitors of Methodos Laboratorio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Methodos Laboratorio
The website of Methodos Laboratorio (methodoslab.com.br) receives about 13.4K visits a month.
- Monthly visits13.4K
▼ 13.3% vs previous month
Websites whose visitors overlap most with Methodos Laboratorio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
methodos.dyndns.info | methodos.dyndns.info | 100% | – | ||
altadiagnosticos.com.br | altadiagnosticos.com.br | 88% | #166,892 | – | |
alvaro.com.br | alvaro.com.br | 75% | #1,357,170 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Methodos Laboratorio
Complete news archive for Methodos Laboratorio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Methodos Laboratorio
Methodos Laboratorio was founded in 1986.
Methodos Laboratorio is headquartered in Pouso Alegre, Brazil. It is registered at Pouso Alegre, Minas Gerais, Brazil.
Methodos Laboratorio was founded in 1986 and functions as a chain of clinical laboratories in Brazil. Operations are centered in Pouso Alegre, with services focused on diagnostic testing and medical analysis. The company serves healthcare needs across the region, providing laboratory examinations and related support in the medical sector. Expansion has been maintained through multiple sites to cover local demands.
Methodos Laboratorio's top competitors include Hermes Pardini, Confiance Medicina Diagnostica and Bioanlise.
Methodos Laboratorio offers Exam Results Platform and Home Collection Service.
Methodos Laboratorio has 1 investor. Key investors include Fleury Medicina e Saúde.
Yes. Methodos Laboratorio was acquired by Fleury Group in October 2022.